Radiopharm Theranostics Files April 2025 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Apr 29, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Radiopharm Theranostics filed its April 6-K, confirming 20-F annual report filings.
AI Summary
Radiopharm Theranostics Limited, on April 29, 2025, filed a Form 6-K with the SEC. This report is for the month of April 2025 and indicates the company will file its annual reports under Form 20-F. The filing does not furnish information under Rule 12g3-2(b).
Why It Matters
This filing provides routine disclosure for foreign private issuers, informing investors about the company's reporting status and adherence to SEC regulations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- Form 20-F (document) — Annual Report Filing Type
- Rule 12g3-2(b) (regulation) — Information Furnishing Rule
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed for the month of April 2025, providing routine disclosures to the SEC.
Which form will Radiopharm Theranostics Limited use for its annual reports?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the company has indicated it is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the Commission File Number for Radiopharm Theranostics Limited?
The Commission File Number for Radiopharm Theranostics Limited is 001-41621.
Where is Radiopharm Theranostics Limited's principal executive office located?
Radiopharm Theranostics Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).